Search tips
Search criteria 


Logo of ccforumBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleCritical CareJournal Front Page
Crit Care. 2010; 14(Suppl 1): P162.
Published online 2010 March 1. doi:  10.1186/cc8394
PMCID: PMC2934170

Metformin increases platelet lactate production by inhibiting mitochondrial function


Metformin improves glucose control by inhibiting hepatocyte mitochondrial complex I [1]. The pathogenesis of metforminassociated lactic acidosis is poorly understood and whether drug accumulation per se can cause hyperlactatemia remains unclear. The aim of the present study is to clarify whether metformin can increase cellular lactate production by inhibiting mitochondrial function in tissues other than the liver.


Platelet-rich-plasma (PRP) from healthy volunteers was incubated for 72 hours with different doses of metformin. The plasma lactate concentration was then measured. The proportion of normally polarized vs abnormally depolarized platelet mitochondria (FL2/FL1) was assessed by flow cytometry after staining with JC-1. Platelet respiratory chain complex I activity and citrate synthase (CS) activity, a marker of mitochondrial content, were measured by spectrophotometry. Data are presented as means ± SD. Analysis was performed with one-way ANOVA.


Main results are reported in Table Table11.


Metformin can cause hyperlactatemia by impairing platelet mitochondrial function.


  • El-Mir MY, Nogueira V, Fontaine E, Avéret N, Rigoulet M, Leverve X. J Biol Chem. 2000. pp. 223–228. [PubMed] [Cross Ref]

Articles from Critical Care are provided here courtesy of BioMed Central